Intellipharmaceutics International Inc. (IPCI)

[cysonic]

Worth to remember:

The blue dye (concrete formula still unknown to the public!) is only released IF someone uses Rexista against directions by crushing it.

So WeeZuhls concerns have no basis and I think Rexista will pass the AdCom.

And the Purdue lawsuit might be a blessing in retrospective, as it potentially allows Rexista to hit the market earlier.

Imho we have a realistic scenario for a "perfect storm" in a bullish context. We should not forget that the current markt cap ($64 million) only reflects the generics pipeline.

IF Rexista gets a positive AdCom recommendation, one has not only to give value to Rexista but also to the nPODDDS technology. And IF they win in the lawsuit, IPCI could generate revenues 3-4-times the current market cap as early as next year!

Show me a biotech stock that has such a great risk/reward-ratio!

cysonic

P.S. PODRAS, Regabatin and other ANDAs/generics come on top!